Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 11 10 2022
accepted: 08 11 2022
entrez: 12 12 2022
pubmed: 13 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Kidney transplantation is the optimal treatment in end-stage kidney disease, but We studied a retrospective cohort of kidney donor:recipient pairs from the Scientific Registry of Transplant Recipients (2000-2015). Allele level HLA-A, B, C, DRB1 and DQB1 types were imputed from serologic types using the NMDP algorithm. TcEMMs were then estimated using the PIRCHE-II algorithm. Multivariable Accelerated Failure Time (AFT) models assessed the association between each TcEMM and DCGF. To discriminate between TcEMMs most predictive of DCGF, we fit multivariable Lasso penalized regression models. We identified co-expressed TcEMMs using weighted correlation network analysis (WGCNA). Finally, we conducted sensitivity analyses to address PIRCHE and IMGT/HLA version updates. A total of 118,309 donor:recipient pairs meeting the eligibility criteria were studied. When applying the PIRCHE-II algorithm, we identified 1,935 distinct TcEMMs at the population level. A total of 218 of the observed TcEMM were independently associated with DCGF by AFT models. The Lasso penalized regression model with post selection inference identified a smaller subset of 86 TcEMMs (56 and 30 TcEMM derived from HLA Class I and II, respectively) to be highly predictive of DCGF. Of the observed TcEMM, 38.14% appeared as profiles of highly co-expressed TcEMMs. In addition, sensitivity analyses identified that the selected TcEMM were congruent across IMGT/HLA versions. In this study, we identified subsets of TcEMMs highly predictive of DCGF and profiles of co-expressed mismatches. Experimental verification of these TcEMMs determining immune responses and how they may interact with EMM as predictors of transplant outcomes would justify their consideration in organ allocation schemes and for modifying immunosuppression regimens.

Identifiants

pubmed: 36505483
doi: 10.3389/fimmu.2022.1067075
pmc: PMC9730505
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067075

Informations de copyright

Copyright © 2022 Lemieux, Fleischer, Yang, Niemann, Oualkacha, Klement, Richard, Polychronakos, Liwski, Claas, Gebel, Keown, Lewin and Sapir-Pichhadze.

Déclaration de conflit d'intérêts

MN is an employee of PIRCHE AG that runs the PIRCHE web-portal. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Transplant. 2012 Feb;12(2):388-99
pubmed: 22081892
Hum Immunol. 2022 Mar;83(3):241-247
pubmed: 35216846
Am J Transplant. 2017 Dec;17(12):3076-3086
pubmed: 28613392
Transplant Proc. 2001 Feb-Mar;33(1-2):493-7
pubmed: 11266924
Kidney Int Rep. 2021 Mar 30;6(6):1567-1579
pubmed: 34169197
Front Immunol. 2021 Dec 21;12:797360
pubmed: 34992608
Hum Immunol. 2022 Mar;83(3):225-232
pubmed: 34844785
Hum Immunol. 2006 Nov;67(11):847-62
pubmed: 17145365
World J Transplant. 2020 Sep 18;10(9):230-255
pubmed: 32995319
Hum Immunol. 2022 Mar;83(3):197-198
pubmed: 35135702
J Heart Lung Transplant. 2022 Jul;41(7):952-960
pubmed: 35437211
Immunogenetics. 2020 Feb;72(1-2):119-129
pubmed: 31741009
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Am J Transplant. 2019 Oct;19(10):2910-2925
pubmed: 31165546
Am J Transplant. 2018 Dec;18(12):2924-2933
pubmed: 29847022
Kidney Int. 2020 Apr;97(4):778-785
pubmed: 32059998
Kidney Int. 2021 Aug;100(2):401-414
pubmed: 33675843
Front Immunol. 2021 Nov 18;12:784040
pubmed: 34868064
Am J Transplant. 2021 Aug;21(8):2833-2845
pubmed: 33725408
J Stat Softw. 2012 Mar;46(11):
pubmed: 23050260
Liver Transpl. 2022 Aug;28(8):1356-1366
pubmed: 35152544
Front Immunol. 2018 Mar 05;9:321
pubmed: 29556227
Am J Transplant. 2019 Jun;19(6):1708-1719
pubmed: 30414349
Am J Transplant. 2019 Oct;19(10):2926-2933
pubmed: 31155833
Nucleic Acids Res. 2020 Jan 8;48(D1):D783-D788
pubmed: 31722398
Ann Transl Med. 2018 Oct;6(20):409
pubmed: 30498736
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Transplantation. 2014 Apr 15;97(7):769-74
pubmed: 24690676
Front Immunol. 2021 Dec 15;12:800968
pubmed: 34975915
Int J Immunogenet. 2022 Apr;49(2):123-167
pubmed: 35119206
Front Immunol. 2020 Aug 27;11:2000
pubmed: 32973806
Int J Immunogenet. 2021 Apr;48(2):135-144
pubmed: 33426788
J Stat Softw. 2011 Mar;39(5):1-13
pubmed: 27065756
HLA. 2018 Jun 10;:
pubmed: 29888504
BMC Bioinformatics. 2015 Nov 17;16:387
pubmed: 26577052
Pediatr Transplant. 2016 Nov;20(7):884-885
pubmed: 27781364

Auteurs

William Lemieux (W)

Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre, Montréal, QC, Canada.
Medical Affairs & Innovation, Héma-Québec, Montréal, QC, Canada.

David Fleischer (D)

Department of Mathematics and Statistics, McGill University, Montreal, QC, Canada.

Archer Yi Yang (AY)

Department of Mathematics and Statistics, McGill University, Montreal, QC, Canada.

Matthias Niemann (M)

Research and Development, PIRCHE AG, Berlin, Germany.

Karim Oualkacha (K)

Department of Mathematics, Université du Québec à Montreal, Montreal, QC, Canada.

William Klement (W)

Division of Organ Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada.

Lucie Richard (L)

Transfusion medicine/Reference Laboratory, Héma-Québec, Montréal, QC, Canada.

Constantin Polychronakos (C)

Department of Pediatrics, The Research Institute of the McGill University Health Centre and the Montreal Children's Hospital, Montréal, QC, Canada.

Robert Liwski (R)

Department of Pathology, Dalhousie University, Halifax, NS, Canada.

Frans Claas (F)

Department of Immunology, Leiden University Medical Centre, Leiden, Netherlands.

Howard M Gebel (HM)

Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.

Paul A Keown (PA)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Antoine Lewin (A)

Medical Affairs & Innovation, Héma-Québec, Montréal, QC, Canada.
Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.

Ruth Sapir-Pichhadze (R)

Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre, Montréal, QC, Canada.
Division of Nephrology and the Multi-Organ Transplant Program, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC, Canada.
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH